23 Results for "

venous thrombosis

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "venous thrombosis" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-125864
CAS No.: 9001-32-5
Fibrinogen (Bovine) is a selective proteolytic molecule that can be activated by thrombin to assemble fibrin clots. Fibrinogen can regulate the activation of NF-KB in endothelial cells and upregulate the expression of inflammatory chemokines MCP-1 and MCP-1. Fibrinogen plays a key role in blood clotting, thrombosis, atherosclerosis and the pathological development of venous grafts, and can be used in the study of blood clotting and vascular diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-125864D
CAS No.: 9001-32-5
Research Areas:  

Cardiovascular Disease

Rabbit Fibrinogen is a native fibrinogen from rabbit plasma. Fibrinogen is a selective proteolytic molecule that can be activated by thrombin to assemble fibrin clots. Fibrinogen can regulate the activation of NF-KB in endothelial cells and upregulate the expression of inflammatory chemokines MCP-1 and MCP-1. Fibrinogen plays a key role in blood clotting, thrombosis, atherosclerosis and the pathological development of venous grafts, and can be used in the study of blood clotting and vascular diseases .
loading...
    loading...
Cat. No.: HY-153530
CAS No.: 2762762-17-2
Purity:  98.95%
Target:  

IPK Superfamily

LI-2242 is an inositol hexakisphosphate kinase (IP6K) inhibitor. LI-2242 has inhibition effect for IP6K1, IP6K2, IP6K3 and IPMK with IC50 values of 31 nM, 42 nM, 8.7 nM and 1944 nM, respectively. LI-2242 can be used for thew research of type II diabetes, obesity, metabolic complications, venous thrombosis, and psychiatric disorders .
loading...
    loading...
Cat. No.: HY-75680
CAS No.: 503614-91-3
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Apixaban ethyl ester is a key intermediate in the synthesis of FXa inhibitors, which is used to study the inhibitory activity against venous thrombosis .
loading...
    loading...
Cat. No.: HY-122592
CAS No.: 1378266-98-8
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Zifaxaban is an orally active, competitively and selective Factor Xa (FXa) inhibitor with an IC50 of 11.1 nM for human FXa. Zifaxaban shows >10000-fold greater selectivity than other serine proteases. Zifaxaban can be used for the arterial and venous thrombosis research .
loading...
    loading...
Cat. No.: HY-A0260
CAS No.: 548-00-5
Research Areas:  

Cardiovascular Disease

Ethyl biscoumacetate is an anticoagulant and vitamin K antagonist. Ethyl biscoumacetate can be used in the research of experimental venous thrombosis .
loading...
    loading...
Cat. No.: HY-19219
CAS No.: 162166-80-5
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

BMS-189664 is a potent, selective, and orally active reversible inhibitor of a-thrombin, with an IC50 of 0.046 μM. BMS-189664 can be used for arterial and venous thrombosis research .
loading...
    loading...
Cat. No.: HY-19219A
CAS No.: 185252-36-2
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

BMS-189664 hydrochloride is a potent, selective, and orally active reversible inhibitor of a-thrombin, with an IC50 of 0.046 μM. BMS-189664 hydrochloride can be used for arterial and venous thrombosis research .
loading...
    loading...
Cat. No.: HY-119680
CAS No.: 294658-50-7
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

AT-1459 is a selective and orally active direct Thrombin inhibitor with a Ki value of 4.9 nM. AT-1459 exhibits excellent antithrombotic activity in both rat models of venous and arterial thrombosis. AT-1459 can be used for research on thrombosis-related diseases .
loading...
    loading...
Cat. No.: HY-10281
CAS No.: 209187-02-0
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

YM-60828 methanesulfonate is an orally active, selective and competitive factor Xa inhibitor with a Ki of 1.3 nM and an IC50 of 2.3 nM. YM-60828 methanesulfonate inhibits thrombus formation and platelet aggregation. YM-60828 methanesulfonate can be used for the research of venous thrombosis, arterial thrombosis, and thromboembolic disorders .
loading...
    loading...
Cat. No.: HY-10270
CAS No.: 871576-03-3
Synonyms: TGN 255
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

Flovagatran (TGN 255) is a potent and reversible thrombin inhibitor (Ki: 9 nM). Flovagatran can be used in the research of arterial and venous thrombosis .
loading...
    loading...
Cat. No.: HY-10271
CAS No.: 871575-98-3
Synonyms: TGN 255 sodium
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

Flovagatran (TGN 255) sodium is a potent and reversible thrombin inhibitor (Ki: 9 nM). Flovagatran sodium can be used in the research of arterial and venous thrombosis .
loading...
    loading...
Cat. No.: HY-14854A
CAS No.: 1004551-83-0
Synonyms: ATI-5923 sodium
Target:  

VKOR

Research Areas:  

Cardiovascular Disease

Tecarfarin (ATI-5923) sodium is an orally active VKOR inhibitor with an IC50 of 0.67 μM against VKORC1. Tecarfarin sodium blocks the post-translational modification of vitamin K-dependent coagulation factors II, VII, IX and X, reducing their levels and activities. Tecarfarin sodium prolongs prothrombin time, attenuates venous and arterial thrombosis, increases ear incision bleeding volume, and exerts reversible anticoagulant effects. Tecarfarin sodium is applicable to research related to arterial and venous thrombosis as well as other diseases requiring anticoagulation .
loading...
    loading...
Cat. No.: HY-14854R
CAS No.: 867257-26-9
Synonyms: ATI-5923 (Standard)
Research Areas:  

Cardiovascular Disease

Tecarfarin (ATI-5923) (Standard) is the analytical standard of Tecarfarin. This product is intended for research and analytical applications. Tecarfarin is an orally active VKOR inhibitor with an IC50 of 0.67 μM against VKORC1. Tecarfarin blocks the post-translational modification of vitamin K-dependent coagulation factors II, VII, IX and X, reducing their levels and activities. Tecarfarin prolongs prothrombin time, attenuates venous and arterial thrombosis, increases ear incision bleeding volume, and exerts reversible anticoagulant effects. Tecarfarin is applicable to research related to arterial and venous thrombosis as well as other diseases requiring anticoagulation .
loading...
    loading...
Cat. No.: HY-120491
CAS No.: 122841-09-2
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

L 722151 is a competitive inhibitor for factor XIIIa with Ki of 49 µM. L 722151 accelerates tissue plasminogen activator-catalyzed clot dissolution, and exhibits antithrombotic efficacy .
loading...
    loading...
Cat. No.: HY-14854S
Synonyms: ATI-5923-13C,d3
Tecarfarin- 13C,d3 (ATI-5923- 13C,d3) is 13C labeled Tecarfarin. Tecarfarin is an orally active VKOR inhibitor with an IC50 of 0.67 μM against VKORC1. Tecarfarin blocks the post-translational modification of vitamin K-dependent coagulation factors II, VII, IX and X, reducing their levels and activities. Tecarfarin prolongs prothrombin time, attenuates venous and arterial thrombosis, increases ear incision bleeding volume, and exerts reversible anticoagulant effects. Tecarfarin is applicable to research related to arterial and venous thrombosis as well as other diseases requiring anticoagulation .
loading...
    loading...
Cat. No.: HY-105919
CAS No.: 120819-70-7
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Naroparcil is an orally active antithrombotic agent. Naroparcil exhibits antithrombotic effects in rabbit Wessler stasis model with EC50s of 21.9 mg/kg and 36.0 mg/kg after respectively intravenous injection and oral administration .
loading...
    loading...
Cat. No.: HY-P2021
CAS No.: 138828-04-3
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

BMS 180742 is a thrombin exosite inhibitor. BMS 180742 does not inhibit arterial thrombosis .
loading...
    loading...
Cat. No.: HY-10279
CAS No.: 179755-65-8
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

YM-60828 hydrochloride is an orally active, selective and competitive factor Xa inhibitor with a Ki of 1.3 nM and an IC50 of 2.3 nM. YM-60828 hydrochloride inhibits thrombus formation and platelet aggregation. YM-60828 hydrochloride can be used for the research of venous thrombosis, arterial thrombosis, and thromboembolic disorders .
loading...
    loading...
Cat. No.: HY-164251
CAS No.: 252271-49-1
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

RWJ-671818 is an orally active inhibitor of human α-thrombin with a Ki of 1.3 nM. RWJ-671818 can be studied in research on venous and arterial thrombosis .
loading...
    loading...